ACOR : Analysis & Opinions

  1. Earnings Miss at Acorda - Analyst Blog

    February 14, 2013
    Acorda Therapeutics Inc.'s (ACOR) fourth quarter earnings (including share-based compensation charges but excluding other ...
  2. Alkermes Maintains Fiscal 2013 View - Analyst Blog

    January 9, 2013
    Alkermes plc (ALKS) recently reaffirmed its view for fiscal 2013 (ending March 31, 2013). The company continues to expect ...
  3. Medivation and Other Big Movers In Healthcare on December 3, ...

    December 3, 2012
    After the morning's trading, the Nasdaq is up 0.2%, the S&P 500 has declined 0.1% and the Dow is trading down 0.2%. The healthcare ...
  4. Alkermes Reverts to Neutral - Analyst Blog

    November 16, 2012
    We are reverting to a Neutral recommendation on Alkermes plc (ALKS) from Outperform as we believe that the stock is fairly ...
  5. Acorda Beats on All Fronts - Analyst Blog

    November 2, 2012
    Acorda Therapeutics Inc. (ACOR) reported third quarter earnings (including share-based compensation charges but excluding ...
  6. Back to Neutral on Alkermes - Analyst Blog

    September 18, 2012
    We are moving back to a Neutral recommendation on Alkermes plc (ALKS) as we believe the stock is fairly valued at current ...
  7. Pharmacyclics Among Healthcare's Biggest Movers on August 28, ...

    August 28, 2012
    On a bad day for the market, the Nasdaq has slipped 0.1%, the S&P 500 is trading down 0.1% and the Dow has decreased 0.1%. ...
  8. Elan Corporation, plc (ADR) and More Big Movers in Healthcare ...

    August 13, 2012
    The market is having a bad day so far. The Nasdaq has declined 0.3%; the S&P 500 is down 0.4%; and the Dow has decreased ...
  9. Acorda Misses on Earnings, Sales Up - Analyst Blog

    August 1, 2012
    Acorda Therapeutics Inc. (ACOR) reported second quarter earnings (including share-based compensation charges but excluding ...
  10. Acorda Commences Patient Enrollment - Analyst Blog

    June 14, 2012
    Acorda Therapeutics, Inc. (ACOR) recently announced the enrollment of the first patient in a proof-of-concept study exploring ...
  11. An Unsurprising Increase In Biotech Acquisitions

    July 28, 2010
    The Sanofi/Genzyme combination isn't the only biotech M&A activity on the radar.
  12. Healthcare Earnings Are Coming Into Focus

    October 30, 2009
    Four names to watch in the healthcare space as their earnings are released Nov. 3.
  13. Large Cap Biotech Earnings Preview

    October 16, 2009
    Biotech stocks traditionally fare well through recessions. We'll see if that holds true.
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center